MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

Jeffrey B. Kopp, Michael W. Smith, George W. Nelson, Randall C. Johnson, Barry I. Freedman, Donald W. Bowden, Taras Oleksyk, Louise M. McKenzie, Hiroshi Kajiyama, Tejinder S. Ahuja, Jeffrey S. Berns, William Briggs, Monique E. Cho, Richard A. Dart, Paul L. Kimmel, Stephen M. Korbet, Donna M. Michel, Michele H. Mokrzycki, Jeffrey R. Schelling, Eric SimonHoward Trachtman, David Vlahov, Cheryl A. Winkler

Research output: Contribution to journalArticlepeer-review

561 Scopus citations

Fingerprint

Dive into the research topics of 'MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences